IMAX Insider Weissman Exercises 7,072 Options, Sells Shares at ~$25.63

Rhea-AI Filing Summary

Kenneth Ian Weissman, IMAX Corp executive (Deputy General Counsel, Corporate Secretary & Chief Compliance Officer), reported option exercise and subsequent share sales on 08/14/2025. He exercised 7,072 stock options with an exercise price of $22.49 (options issued in 2019, expiring 03/07/2026) converting them into 7,072 common shares. The filing shows two dispositions the same day: sale of 7,072 shares at $25.6707 and sale of 8,000 shares at $25.6272.

Ownership changed from an opening balance of 34,133 common shares to a post-transaction balance of 26,133 common shares. The filing notes Mr. Weissman retains 17,021 restricted share units outstanding and that the exercised options were vested in installments between 2020 and 2023.

Positive

• Options exercised at $22.49 and sold at higher prices (~$25.63–$25.67), indicating a realized gain before taxes and fees
• Clear disclosure of vesting schedule and option expiration (03/07/2026) improves transparency for investors

Negative

• Net reduction in common shares from 34,133 to 26,133, representing decreased insider ownership in absolute terms
• No explicit 10b5-1 plan referenced in the filing, so sales appear to be discretionary rather than under a pre-established trading plan

Insights

Securities Analyst

TL;DR: Routine option exercise followed by same-day sales; small net reduction in holdings, consistent with typical executive liquidity actions.

The report documents conversion of 7,072 options at a $22.49 exercise price and immediate sales at roughly $25.63–$25.67, implying a per-share spread realized before fees and taxes. The transactions appear non-controversial and do not indicate new compensation terms or extraordinary transfers. Remaining common shares total 26,133 with 17,021 RSUs outstanding, leaving material ownership intact relative to routine insider activity.

Corporate Governance Expert

TL;DR: Disclosure follows Rule 16 reporting norms; vesting schedule and option expiry are clearly stated.

The Form 4 discloses exercisable option tranches (1,414; 1,768; 1,768; 2,122) and the 03/07/2026 expiration, which helps trace long-term incentive timing. Sales executed the same day as exercise may reflect pre-arranged liquidity or tax-driven decisions; the filing does not state a 10b5-1 plan. No departures, grants, or other governance events are reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weissman Kenneth Ian

(Last) (First) (Middle)

902 BROADWAY

20TH FLOOR

(Street)

NEW YORK NY 10010-6002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Deputy GC, Corp. Sec. & CCO

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								34,133	D
common shares	08/14/2025		C		7,072(1)	A	$22.49	41,205	D
common shares	08/14/2025		S		7,072	D	$25.6707	34,133	D
common shares	08/14/2025		S		8,000	D	$25.6272	26,133	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock options (to buy)(2)	$22.49	08/14/2025		C			7,072	(3)	03/07/2026	common shares	7,072	$22.49	0(4)	D

Explanation of Responses:

1. Represents the conversion upon exercise of stock options into common shares.

2. These options were issued in 2019 and are set to expire on March 7, 2026.

3. The stock options became exercisable in four installments: 1,414 on March 7, 2020, 1,768 on each of March 7, 2021 and March 7, 2022, and 2,122 on March 7, 2023.

4. This represents the number of restricted share units for this transaction only. Mr. Weissman's aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 17,021 and 26,133. respectively.

Remarks:

	Kenneth Ian Weissman	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did IMAX (IMAX) insider Kenneth Weissman report on 08/14/2025?

Mr. Weissman exercised 7,072 stock options at $22.49 and sold 7,072 shares at $25.6707 and 8,000 shares at $25.6272 the same day.

How many IMAX shares does Kenneth Weissman own after the reported transactions?

Following the reported transactions Mr. Weissman beneficially owns 26,133 common shares and has 17,021 restricted share units outstanding.

What were the terms of the exercised options reported by the IMAX insider?

The options had an exercise price of $22.49, were issued in 2019, vested in four installments (1,414; 1,768; 1,768; 2,122) and expire on 03/07/2026.

Do the filings indicate a 10b5-1 trading plan for these sales by IMAX insider?

The Form 4 does not indicate that these transactions were made pursuant to a 10b5-1 trading plan.

Did the insider realize a gain on these IMAX transactions?

Based on exercise at $22.49 and sales near $25.63–$25.67, the transactions imply a per-share spread realized before taxes and fees.